✦ LIBER ✦

Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen?

✍ Scribed by Patrick Marcellin; E. Jenny Heathcote; Antonio Craxì

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Which patients with geno

✍ Patrick Marcellin; E. Jenny Heathcote; Antonio Craxì 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Randomised clinical trial: pre-dosing wi

✍ M. Palmer; R. Rubin; V. Rustgi; Taribavirin Viral Kinetic Study Group 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Treatment extension may benefit female g

✍ Takeshi Nishimura; Kanji Yamaguchi; Hiroaki Hashimoto; Toshihisa Niimi; Chihiro 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

PIN62 Cost-Effectiveness of Triple Thera

✍ J.T. Stahmeyer; S. Schauer; D. Wirth; J. Fleischmann; S. Lee; S. Gavart; F. Bian 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Clinical utility of the ARCHITECT HCV Ag

✍ Johannes Vermehren; Simone Susser; Annemarie Berger; Dany Perner; Kai-Henrik Pei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 300 KB

PIN32 Economic Evaluation of Boceprevir

✍ R. Odhiambo; J. Chhatwal; S.A. Ferrante; A. El Khoury; E. Elbasha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB